ArticleInternal medicine (Tokyo, Japan)2021
Erratum for Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center.
Chinatsu Takai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.